057 Rethinking the Techno Vagina: A Case Series of Patient Complications Following Vaginal Laser Treatment for Atrophy

Abstract

Listen

Translate article

Approximately 40-80% of postmenopausal women endure a variety of symptoms associated with genitourinary syndrome of menopause (GSM). Currently, many treatment options exist for this medical condition, including prescription hormone therapy, non-hormonal over the counter products, and most recently laser treatment. While the Food and Drug Administration (FDA) has cleared fractional CO2 laser for a variety of dermatologic and gynecologic indications, lasers have not to date, been approved for use for vulvar/ vaginal atrophy, vaginal laxity, deceased sexual function, or dyspareunia.